[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

2015-2025 Global Multiple Sclerosis (MS) Drugs Market Research by Type, End-Use and Region

July 2024 | 150 pages | ID: 29BE738C92FAEN
99Strategy

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

The global Multiple Sclerosis (MS) Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:
  • Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
  • Chapter 2: Global Production & Consumption Market by Type and End-Use
  • Chapter 3: Europe Production & Consumption Market by Type and End-Use
  • Chapter 4: America Production & Consumption Market by Type and End-Use
  • Chapter 5: Asia Production & Consumption Market by Type and End-Use
  • Chapter 6: Oceania Production & Consumption Market by Type and End-Use
  • Chapter 7: Africa Production & Consumption Market by Type and End-Use
  • Chapter 8: Global Market Forecast by Type, End-Use and Region
  • Chapter 9: Company information, Sales, Cost, Margin, news etc.
  • Chapter 10: Market Competition by Companies and Market Concentration Ratio
  • Chapter 11: Market Impact by Coronavirus.
  • Chapter 12: Industry Summary
Market Segment as follows:

Key Companies
  • Bayer AG
  • Bayhill Therapeutics
  • Biogen Idec
  • Cinnagen
  • Daiichi Sankyo
  • Eli Lilly
  • Fast Forward Llc
  • Antisense Therapeutics
  • Apitope
  • Five Prime Therapeutics
  • Genmab
  • Artielle Immunotherapeutics
  • Genzyme
  • Glaxosmithkline
  • Gw Pharmaceuticals
  • Innate Immunotherapeutics
Key Types
  • Copaxone (Glatiramer Acetate, Copolymer 1)
  • Novantrone (Mitoxantrone)
  • Gilenya (Fingolimod, Fty720)
  • Aubagio (Teriflunomide)
  • Tecfidera (Dimethyl Fumarate)
  • Firategrast (Sb683699, T-0047)
  • Siponimod (Baf312)
  • Others
Key End-Use
  • RRMS
  • SPMS
  • PPMS
  • PRMS
This report can be dispatched within 24-48 Hours.
CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe Multiple Sclerosis (MS) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Multiple Sclerosis (MS) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America Multiple Sclerosis (MS) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Multiple Sclerosis (MS) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia Multiple Sclerosis (MS) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaMultiple Sclerosis (MS) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania Multiple Sclerosis (MS) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Multiple Sclerosis (MS) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa Multiple Sclerosis (MS) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Multiple Sclerosis (MS) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global Multiple Sclerosis (MS) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Multiple Sclerosis (MS) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Multiple Sclerosis (MS) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2020 (Million USD)
Table Global Multiple Sclerosis (MS) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Global Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Multiple Sclerosis (MS) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe Multiple Sclerosis (MS) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Multiple Sclerosis (MS) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Multiple Sclerosis (MS) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Europe Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2020 (Million USD)
Table Europe Multiple Sclerosis (MS) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Europe Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Multiple Sclerosis (MS) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America Multiple Sclerosis (MS) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Multiple Sclerosis (MS) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Multiple Sclerosis (MS) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure America Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2020 (Million USD)
Table America Multiple Sclerosis (MS) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure America Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table America Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Multiple Sclerosis (MS) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia Multiple Sclerosis (MS) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Multiple Sclerosis (MS) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Multiple Sclerosis (MS) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Asia Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2020 (Million USD)
Table Asia Multiple Sclerosis (MS) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Asia Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Multiple Sclerosis (MS) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania Multiple Sclerosis (MS) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Multiple Sclerosis (MS) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Multiple Sclerosis (MS) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2020 (Million USD)
Table Oceania Multiple Sclerosis (MS) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Multiple Sclerosis (MS) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa Multiple Sclerosis (MS) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Multiple Sclerosis (MS) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Multiple Sclerosis (MS) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Africa Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2020 (Million USD)
Table Africa Multiple Sclerosis (MS) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Africa Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Multiple Sclerosis (MS) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global Multiple Sclerosis (MS) Drugs Production Forecast
Figure Global Multiple Sclerosis (MS) Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Multiple Sclerosis (MS) Drugs Forecast by Type
Table Global Multiple Sclerosis (MS) Drugs Revenue by Type, 2020E-2025F (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2025 (Million USD)
Table Global Multiple Sclerosis (MS) Drugs Production Volume by Type, 2020E-2025F (Volume)
Figure Global Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2025 (Volume)
8.3 Global Multiple Sclerosis (MS) Drugs Forecast by End-Use (2020E-2025F)
Table Global Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Multiple Sclerosis (MS) Drugs Forecast by Region (2020E-2025F)
Table Global Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Consumption Value Share by Region in 2025 (Million USD)
Table Global Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Multiple Sclerosis (MS) Drugs Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Bayer AG
  9.1.1 Bayer AG Profile
Table Bayer AG Overview List
  9.1.2 Bayer AG Products & Services
  9.1.3 Bayer AG Company Dynamics & News
  9.1.4 Bayer AG Business Operation Conditions
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Bayhill Therapeutics
  9.2.1 Bayhill Therapeutics Profile
Table Bayhill Therapeutics Overview List
  9.2.2 Bayhill Therapeutics Products & Services
  9.2.3 Bayhill Therapeutics Company Dynamics & News
  9.2.4 Bayhill Therapeutics Business Operation Conditions
Table Business Operation of Bayhill Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Biogen Idec
  9.3.1 Biogen Idec Profile
Table Biogen Idec Overview List
  9.3.2 Biogen Idec Products & Services
  9.3.3 Biogen Idec Company Dynamics & News
  9.3.4 Biogen Idec Business Operation Conditions
Table Business Operation of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Cinnagen
  9.4.1 Cinnagen Profile
Table Cinnagen Overview List
  9.4.2 Cinnagen Products & Services
  9.4.3 Cinnagen Company Dynamics & News
  9.4.4 Cinnagen Business Operation Conditions
Table Business Operation of Cinnagen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Daiichi Sankyo
  9.5.1 Daiichi Sankyo Profile
Table Daiichi Sankyo Overview List
  9.5.2 Daiichi Sankyo Products & Services
  9.5.3 Daiichi Sankyo Company Dynamics & News
  9.5.4 Daiichi Sankyo Business Operation Conditions
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Eli Lilly
  9.6.1 Eli Lilly Profile
Table Eli Lilly Overview List
  9.6.2 Eli Lilly Products & Services
  9.6.3 Eli Lilly Company Dynamics & News
  9.6.4 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Fast Forward Llc
  9.7.1 Fast Forward Llc Profile
Table Fast Forward Llc Overview List
  9.7.2 Fast Forward Llc Products & Services
  9.7.3 Fast Forward Llc Company Dynamics & News
  9.7.4 Fast Forward Llc Business Operation Conditions
Table Business Operation of Fast Forward Llc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Antisense Therapeutics
  9.8.1 Antisense Therapeutics Profile
Table Antisense Therapeutics Overview List
  9.8.2 Antisense Therapeutics Products & Services
  9.8.3 Antisense Therapeutics Company Dynamics & News
  9.8.4 Antisense Therapeutics Business Operation Conditions
Table Business Operation of Antisense Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Apitope
  9.9.1 Apitope Profile
Table Apitope Overview List
  9.9.2 Apitope Products & Services
  9.9.3 Apitope Company Dynamics & News
  9.9.4 Apitope Business Operation Conditions
Table Business Operation of Apitope (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Five Prime Therapeutics
  9.10.1 Five Prime Therapeutics Profile
Table Five Prime Therapeutics Overview List
  9.10.2 Five Prime Therapeutics Products & Services
  9.10.3 Five Prime Therapeutics Company Dynamics & News
  9.10.4 Five Prime Therapeutics Business Operation Conditions
Table Business Operation of Five Prime Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Genmab
  9.11.1 Genmab Profile
Table Genmab Overview List
  9.11.2 Genmab Products & Services
  9.11.3 Genmab Company Dynamics & News
  9.11.4 Genmab Business Operation Conditions
Table Business Operation of Genmab (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Artielle Immunotherapeutics
  9.12.1 Artielle Immunotherapeutics Profile
Table Artielle Immunotherapeutics Overview List
  9.12.2 Artielle Immunotherapeutics Products & Services
  9.12.3 Artielle Immunotherapeutics Company Dynamics & News
  9.12.4 Artielle Immunotherapeutics Business Operation Conditions
Table Business Operation of Artielle Immunotherapeutics (Sales Revenue, Cost, Gross Margin)
9.13 Genzyme
  9.13.1 Genzyme Profile
Table Genzyme Overview List
  9.13.2 Genzyme Products & Services
  9.13.3 Genzyme Company Dynamics & News
  9.13.4 Genzyme Business Operation Conditions
Table Business Operation of Genzyme (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Glaxosmithkline
  9.14.1 Glaxosmithkline Profile
Table Glaxosmithkline Overview List
  9.14.2 Glaxosmithkline Products & Services
  9.14.3 Glaxosmithkline Company Dynamics & News
  9.14.4 Glaxosmithkline Business Operation Conditions
Table Business Operation of Glaxosmithkline (Sales Revenue, Cost, Gross Margin)
9.15 Gw Pharmaceuticals
  9.15.1 Gw Pharmaceuticals Profile
Table Gw Pharmaceuticals Overview List
  9.15.2 Gw Pharmaceuticals Products & Services
  9.15.3 Gw Pharmaceuticals Company Dynamics & News
  9.15.4 Gw Pharmaceuticals Business Operation Conditions
Table Business Operation of Gw Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.16 Innate Immunotherapeutics
  9.16.1 Innate Immunotherapeutics Profile
Table Innate Immunotherapeutics Overview List
  9.16.2 Innate Immunotherapeutics Products & Services
  9.16.3 Innate Immunotherapeutics Company Dynamics & News
  9.16.4 Innate Immunotherapeutics Business Operation Conditions
Table Business Operation of Innate Immunotherapeutics (Sales Revenue, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global Multiple Sclerosis (MS) Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Multiple Sclerosis (MS) Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Multiple Sclerosis (MS) Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Multiple Sclerosis (MS) Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Multiple Sclerosis (MS) Drugs Market Concentration Ratio in 2020E
Figure America Multiple Sclerosis (MS) Drugs Market Concentration Ratio in 2020E
Figure Asia Multiple Sclerosis (MS) Drugs Market Concentration Ratio in 2020E
Figure Oceania Multiple Sclerosis (MS) Drugs Market Concentration Ratio in 2020E
Figure Africa Multiple Sclerosis (MS) Drugs Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON MULTIPLE SCLEROSIS (MS) DRUGS INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 MULTIPLE SCLEROSIS (MS) DRUGS INDUSTRY SUMMARY & CONCLUSION
LIST OF TABLES
Table Global Multiple Sclerosis (MS) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Global Multiple Sclerosis (MS) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Global Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Multiple Sclerosis (MS) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Multiple Sclerosis (MS) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Multiple Sclerosis (MS) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Europe Multiple Sclerosis (MS) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Europe Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table America Multiple Sclerosis (MS) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Multiple Sclerosis (MS) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Multiple Sclerosis (MS) Drugs Revenue by Type, 2015-2020 (Million USD)
Table America Multiple Sclerosis (MS) Drugs Production Volume by Type, 2015-2020 (Volume)
Table America Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Multiple Sclerosis (MS) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Multiple Sclerosis (MS) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Multiple Sclerosis (MS) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Asia Multiple Sclerosis (MS) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Asia Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Multiple Sclerosis (MS) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Multiple Sclerosis (MS) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Multiple Sclerosis (MS) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Oceania Multiple Sclerosis (MS) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Oceania Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Multiple Sclerosis (MS) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Multiple Sclerosis (MS) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Multiple Sclerosis (MS) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Africa Multiple Sclerosis (MS) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Africa Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Global Multiple Sclerosis (MS) Drugs Revenue by Type, 2020E-2025F (Million USD)
Table Global Multiple Sclerosis (MS) Drugs Production Volume by Type, 2020E-2025F (Volume)
Table Global Multiple Sclerosis (MS) Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Multiple Sclerosis (MS) Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Multiple Sclerosis (MS) Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Multiple Sclerosis (MS) Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Table Bayer AG Overview List
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayhill Therapeutics Overview List
Table Business Operation of Bayhill Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biogen Idec Overview List
Table Business Operation of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cinnagen Overview List
Table Business Operation of Cinnagen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fast Forward Llc Overview List
Table Business Operation of Fast Forward Llc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Antisense Therapeutics Overview List
Table Business Operation of Antisense Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Apitope Overview List
Table Business Operation of Apitope (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Five Prime Therapeutics Overview List
Table Business Operation of Five Prime Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genmab Overview List
Table Business Operation of Genmab (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Artielle Immunotherapeutics Overview List
Table Business Operation of Artielle Immunotherapeutics (Sales Revenue, Cost, Gross Margin)
Table Genzyme Overview List
Table Business Operation of Genzyme (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Glaxosmithkline Overview List
Table Business Operation of Glaxosmithkline (Sales Revenue, Cost, Gross Margin)
Table Gw Pharmaceuticals Overview List
Table Business Operation of Gw Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Innate Immunotherapeutics Overview List
Table Business Operation of Innate Immunotherapeutics (Sales Revenue, Cost, Gross Margin)
Table Global Multiple Sclerosis (MS) Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Multiple Sclerosis (MS) Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Multiple Sclerosis (MS) Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Multiple Sclerosis (MS) Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
LIST OF FIGURES
Figure Europe Multiple Sclerosis (MS) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Multiple Sclerosis (MS) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Multiple Sclerosis (MS) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Multiple Sclerosis (MS) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Multiple Sclerosis (MS) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaMultiple Sclerosis (MS) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Multiple Sclerosis (MS) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Multiple Sclerosis (MS) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Multiple Sclerosis (MS) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Multiple Sclerosis (MS) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2020 (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2020 (Volume)
Figure Global Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2020 (Million USD)
Figure Europe Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2020 (Volume)
Figure Europe Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Multiple Sclerosis (MS) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2020 (Million USD)
Figure America Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2020 (Volume)
Figure America Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Multiple Sclerosis (MS) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2020 (Million USD)
Figure Asia Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2020 (Volume)
Figure Asia Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Multiple Sclerosis (MS) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2020 (Million USD)
Figure Oceania Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2020 (Volume)
Figure Oceania Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Multiple Sclerosis (MS) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2020 (Million USD)
Figure Africa Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2020 (Volume)
Figure Africa Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Multiple Sclerosis (MS) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Multiple Sclerosis (MS) Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Share by Type in 2025 (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Production Volume Share by Type in 2025 (Volume)
Figure Global Multiple Sclerosis (MS) Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Consumption Value Share by Region in 2025 (Million USD)
Figure Global Multiple Sclerosis (MS) Drugs Consumption Volume Share by Region in 2025 (Volume)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories